AVNS, US05350V1061

Avanos Medical stock trades at USD 24.99 after buyout completed

Published on 10/04/2026 at 09:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Avanos Medical stock last traded at USD 24.99 on July 24, 2026, 1.96 percent below its 52-week high. First-quarter revenue rose 8.78 percent.

AVNS, US05350V1061, Illustration mit AI erstellt.
AVNS, US05350V1061, Illustration mit AI erstellt.

Avanos Medical stock (ISIN US05350V1061) last traded at USD 24.99 on the NYSE on July 24, 2026, leaving the price 1.96 percent below its 52-week high of USD 25.49. The latest company development came on October 1, 2026, when PR Newswire reported the US launch of Game Ready's over-the-counter recovery system.

Game Ready reaches consumers

The launch expands Game Ready beyond prescription and clinical use into direct consumer sales. Avanos said the system is available through GameReady.com and Amazon.com, while prescription applications continue serving post-surgical and healthcare-provider-directed care.

The move gives the brand a new commercial channel after a major ownership change. 6ix lists American Industrial Partners' acquisition of Avanos as completed on July 27, 2026, following the stockholders' approval on July 22, 2026.

Revenue rose in Q1 2026

Before the transaction closed, Avanos reported USD 182.20 million of first-quarter 2026 revenue, up 8.78 percent from USD 167.50 million in the year-earlier quarter. According to StockTitan on May 5, 2026, net income was USD 5.10 million, down from USD 6.60 million, while diluted earnings per share came to USD 0.11.

Operating income stood at USD 8.90 million in Q1 2026, compared with the revenue increase that reflected continued demand in Avanos' medical technology portfolio. The numbers show a mixed operating picture: sales expanded, but reported profit declined year over year.

NYSE snapshot before the deal

The final structured quote shows USD 24.99, a USD 0.01 increase, or 0.04 percent, from the prior close of USD 24.98 on July 24, 2026 at 4:03 p.m. ET. The session range was USD 24.98 to USD 25.00, with volume of 432,161 shares.

Avanos Medical's market capitalization was USD 1.2 billion on July 24, 2026, and the 52-week range was USD 9.30 to USD 25.49. wallstreetONLINE identifies the security as Avanos Medical with ISIN US05350V1061, while 6ix identifies AVNS as the NYSE listing in USD.

Avanos Medical stock data

  • Company: Avanos Medical, Inc.
  • ISIN: US05350V1061
  • Ticker: AVNS
  • Trading venue: NYSE
  • Price (as of July 24, 2026, 4:03 p.m. ET): USD 24.99
  • Market capitalization: USD 1.2 billion (as of July 24, 2026)
  • 52-week range: USD 9.30-25.49 (as of July 24, 2026)
  • Sector / Industry: Healthcare / Medical Devices

More news and analyses on Avanos Medical stock

Disclaimer...

en | US05350V1061 | AVNS | boerse | 70223721 | bgmi